Dylan G. Scholes

Dylan G. Scholes, BS, is a Clinical Research Coordinator on the Airways Research Team for the Clinical Research Unit (CRU) at the Abramson Cancer Center. Dylan collaborates with PC3I faculty on innovative initiatives focused on improving cancer care.

Mr. Scholes currently assists with the iNUDGE clinical trial that is aimed at improving comprehensive molecular testing rates for lung cancer patients. Before joining the CRU, Mr. Scholes worked in the Division of Oncology at the Children’s Hospital of Philadelphia (CHOP), where he focused on the use of patient-reported outcomes for symptom tracking in pediatric cancer patients. Mr. Scholes’s prior experiences include working as a Research Assistant in the Liquid Biopsy Core at the Center for Cellular Immunotherapies.

Mr. Scholes received his Bachelor of Science degree in Biology and Organismal Physiology from Drexel University.

Dylan’s Work

iNUDGE: Integration of Liquid Biopsy Based Next Generation Gene Sequencing in Newly Diagnosed NSCLC

• Behavior Change
• Clinical Transformation

Optimizing Biomarker Detection and Extending Life for Patients with Non-Small Cell Lung Cancer

• Behavior Change
• Clinical Transformation